Michael Moran

Bio:

Michael Moran is U.S. Head of Commercial Development at Henlius, responsible for advancing the company’s commercial development strategy in the United States and strengthening its commercial capabilities to support long-term growth in the market.

Michael brings more than 30 years of pharmaceutical industry experience, with deep expertise in oncology, specialty pharmaceuticals, biosimilars, hospital and specialty commercialization, and commercial organization build-outs. Throughout his career, he has successfully led commercial transformations, launch initiatives, and high-performing sales and market access organizations across complex and highly competitive healthcare markets.

Prior to joining Henlius, Michael held senior commercial leadership roles at GSK, Eagle Pharmaceuticals, and Syneos Health, where he led large-scale commercial organizations, supported multiple product launches, and drove significant business growth across both established and emerging therapeutic markets. He also served as an independent strategic advisor to pharmaceutical leadership teams, supporting commercial strategy, organizational design, and growth initiatives.

Michael holds a Bachelor of Science degree in Business Management from the State University of New York.